Skip to content

Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.

The Effects of Experiential HIV Testing to Improve Knowledge and Practice, and Reduce Stigma Toward HIV of Emergency Department Nurses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05615935
Enrollment
74
Registered
2022-11-14
Start date
2022-11-09
Completion date
2023-02-23
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv, HIV Testing

Keywords

stigma, knowledge, Education, nursing, situated learning

Brief summary

This is a randomized controlled trial design. The investigators plan to recruit about 60 to 70 emergency department nurses from a medical center in Taipei, Taiwan. After completing the paper consent form, these nurses will be randomly assigned to 2 groups, which are a control group and an experimental group. The pre-test includes the demographic data sheet, HIV testing related knowledge and practice scale, and The Health Care Provider HIV/ AIDS Stigma Scale (HPASS). All nurses will receive a learning material when they finish the pre-test. In addition, the experimental group will be provided a real HIV testing and counselling by a researcher. The post-test will be finished one month later of pre-test in the control group, and one month later while the intervention completed in the experimental group. The semi-structural interview will be performed to the experimental group to collect and analyze their opinion toward the experiential HIV testing.

Detailed description

This project aims to develop an intervention of experiential HIV testing and to verify the following effects on emergency nurses: (1) Improve HIV testing related knowledge and practice; (2) Reduce HIV-related stigma; (3) Find out the possible demographic factors that might affect the effectiveness of experiential HIV Testing. During the intervention, nurses can directly participate in the whole process of anonymous HIV testing in the role of who need to be screened, and pre- and post-testing counselling accompanied the education and discussion will also be provided to them by a researcher. Through the above-mentioned measures, the knowledge and practices related to the HIV testing could be improved, and the stigma attitude toward HIV could be reduced through the self-reflection on the testing process.

Interventions

OTHERExperiential HIV Testing

The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.

Sponsors

National Taiwan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- have registered nurse license and do clinical care in emergency department

Exclusion criteria

* have registered nurse license but doesn't do clinical care, likes head nurse. * do clinical care in emergency department but doesn't have registered nurse license, like volunteers or assistant nurse. * have experienced non-occupational HIV testing. * had been a nurse in HIV/AIDS-focus ward or HIV/AIDS case manager.

Design outcomes

Primary

MeasureTime frameDescription
HIV Testing Related Knowledge and Practicepre-test(Baseline) and post-test (week 4)A self-development scale, known as the HIV Testing-Related Knowledge and Practice Scale, is employed to assess individuals' knowledge and practices pertaining to HIV testing. The scale consists of twenty-eight questions, encompassing both True-False and multiple-choice formats. Participants earn one point for each correct answer, contributing to a total score that ranges from the minimum scores of 0 to the maximum scores of 28. Higher scores signify a more positive outcome, indicating enhanced HIV testing-related knowledge and practice among the participants.
HIV Related Stigmapre-test (Baseline) and post-test (Week 4)The Healthcare Provider HIV/AIDS Stigma Scale (HPASS) will be used to assess this outcome. The instrument contains 30 items, each scored on a six-point Likert scale, yielding a minimum total score of 30 and a maximum of 180. Higher scores reflect greater levels of stigma toward people living with HIV, indicating a worse outcome. Validation of the HPASS through factor analysis identified three underlying dimensions. The stereotyping dimension (11 items; score range: 11-66) reflects negative cognitions and beliefs about people living with HIV. The prejudice dimension (13 items; score range: 13-78) captures emotionally driven attitudes. The discrimination dimension (6 items; score range: 6-36) represents behavioral responses stemming from negative attitudes. For all dimensions, higher scores indicate worse outcomes. These 3 dimensions(as sub-scale scores) for stereotyping, prejudice, and discrimination will also be calculated and analyzed.

Countries

Taiwan

Participant flow

Participants by arm

ArmCount
Get a Learning Material and a Experiential HIV Testing
These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided. Experiential HIV Testing: The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.
36
Get a Learning Material Only
These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.
36
Total72

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicGet a Learning Material and a Experiential HIV TestingGet a Learning Material OnlyTotal
Age, Continuous28.03 years
STANDARD_DEVIATION 4.58
29.14 years
STANDARD_DEVIATION 5.74
28.58 years
STANDARD_DEVIATION 5.19
catastrophic illness
no
36 Participants35 Participants71 Participants
catastrophic illness
yes
0 Participants1 Participants1 Participants
education level
bachelor's degree
33 Participants33 Participants66 Participants
education level
master's degree
3 Participants3 Participants6 Participants
ever had HIV occupational exposure or not
no
25 Participants25 Participants50 Participants
ever had HIV occupational exposure or not
yes
11 Participants11 Participants22 Participants
Marital status
married
4 Participants6 Participants10 Participants
Marital status
single
32 Participants30 Participants62 Participants
Nursing practice years5.06 years
STANDARD_DEVIATION 4.49
6.18 years
STANDARD_DEVIATION 5.28
5.62 years
STANDARD_DEVIATION 4.9
Nursing practice years in the ED3.6 years
STANDARD_DEVIATION 3.64
4.77 years
STANDARD_DEVIATION 4.32
4.18 years
STANDARD_DEVIATION 4.01
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
36 Participants36 Participants72 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
receiving HIV-related lecture in recent 12 months
no
25 Participants26 Participants51 Participants
receiving HIV-related lecture in recent 12 months
yes
11 Participants10 Participants21 Participants
Region of Enrollment
Taiwan
36 participants36 participants72 participants
religion
Buddhism
3 Participants7 Participants10 Participants
religion
Buddhism and Taoism
1 Participants2 Participants3 Participants
religion
Catholicism
1 Participants0 Participants1 Participants
religion
Christianity
2 Participants2 Participants4 Participants
religion
None
23 Participants19 Participants42 Participants
religion
Taoism
6 Participants6 Participants12 Participants
Sex: Female, Male
Female
28 Participants28 Participants56 Participants
Sex: Female, Male
Male
8 Participants8 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 720 / 72
other
Total, other adverse events
0 / 720 / 72
serious
Total, serious adverse events
0 / 720 / 72

Outcome results

Primary

HIV Related Stigma

The Healthcare Provider HIV/AIDS Stigma Scale (HPASS) will be used to assess this outcome. The instrument contains 30 items, each scored on a six-point Likert scale, yielding a minimum total score of 30 and a maximum of 180. Higher scores reflect greater levels of stigma toward people living with HIV, indicating a worse outcome. Validation of the HPASS through factor analysis identified three underlying dimensions. The stereotyping dimension (11 items; score range: 11-66) reflects negative cognitions and beliefs about people living with HIV. The prejudice dimension (13 items; score range: 13-78) captures emotionally driven attitudes. The discrimination dimension (6 items; score range: 6-36) represents behavioral responses stemming from negative attitudes. For all dimensions, higher scores indicate worse outcomes. These 3 dimensions(as sub-scale scores) for stereotyping, prejudice, and discrimination will also be calculated and analyzed.

Time frame: pre-test (Baseline) and post-test (Week 4)

ArmMeasureGroupValue (MEAN)Dispersion
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(pre-test)HPASS in total89.39 score on a scaleStandard Deviation 16.14
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(post-test)HPASS in total85.94 score on a scaleStandard Deviation 20.1
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(pre-test)stereotyping36.36 score on a scaleStandard Deviation 6.85
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(post-test)stereotyping36.31 score on a scaleStandard Deviation 7.66
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(pre-test)prejudice35.78 score on a scaleStandard Deviation 8.51
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(post-test)prejudice33.14 score on a scaleStandard Deviation 10.73
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(pre-test)discrimination17.25 score on a scaleStandard Deviation 5.61
Get a Learning Material and a Experiential HIV TestingHIV Related Stigma(post-test)discrimination16.50 score on a scaleStandard Deviation 5.59
Get a Learning Material OnlyHIV Related Stigma(post-test)discrimination15.28 score on a scaleStandard Deviation 5.32
Get a Learning Material OnlyHIV Related Stigma(pre-test)HPASS in total86.75 score on a scaleStandard Deviation 22.06
Get a Learning Material OnlyHIV Related Stigma(pre-test)prejudice34.44 score on a scaleStandard Deviation 12.11
Get a Learning Material OnlyHIV Related Stigma(post-test)HPASS in total88.03 score on a scaleStandard Deviation 20.44
Get a Learning Material OnlyHIV Related Stigma(pre-test)discrimination13.94 score on a scaleStandard Deviation 5.68
Get a Learning Material OnlyHIV Related Stigma(pre-test)stereotyping38.36 score on a scaleStandard Deviation 8.43
Get a Learning Material OnlyHIV Related Stigma(post-test)prejudice34.72 score on a scaleStandard Deviation 10.31
Get a Learning Material OnlyHIV Related Stigma(post-test)stereotyping38.03 score on a scaleStandard Deviation 9.2
p-value: 0.15ANCOVA
p-value: 0.02t-test, 2 sided
Primary

HIV Testing Related Knowledge and Practice

A self-development scale, known as the HIV Testing-Related Knowledge and Practice Scale, is employed to assess individuals' knowledge and practices pertaining to HIV testing. The scale consists of twenty-eight questions, encompassing both True-False and multiple-choice formats. Participants earn one point for each correct answer, contributing to a total score that ranges from the minimum scores of 0 to the maximum scores of 28. Higher scores signify a more positive outcome, indicating enhanced HIV testing-related knowledge and practice among the participants.

Time frame: pre-test(Baseline) and post-test (week 4)

ArmMeasureGroupValue (MEAN)Dispersion
Get a Learning Material and a Experiential HIV TestingHIV Testing Related Knowledge and Practicepost-test19.44 score on a scaleStandard Deviation 2.21
Get a Learning Material and a Experiential HIV TestingHIV Testing Related Knowledge and Practicepre-test17.17 score on a scaleStandard Deviation 1.88
Get a Learning Material OnlyHIV Testing Related Knowledge and Practicepre-test17.22 score on a scaleStandard Deviation 2.14
Get a Learning Material OnlyHIV Testing Related Knowledge and Practicepost-test17.36 score on a scaleStandard Deviation 2.69
Comparison: Using G\*Power 3.1, the required sample size for ANCOVA with two groups was estimated with a significance level of 0.05, statistical power of 0.80, and an effect size of 0.35, based on Cohen's guidelines for a medium-to-large effect commonly applied in behavioral research (Cohen, 1988). Assuming up to two covariates, a minimum of 67 participants was required. Accounting for a 10% attrition rate, the final target was set at 74 participants.p-value: <0.001ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026